Medicare Enrolled
Dr. Jason Smith, M D
Procedural Dermatology Physician · Rome, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Smith
Dr. Jason Smith is a procedural dermatology physician in Rome, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Smith performed 11,080 Medicare services across 5,735 unique beneficiaries.
Between the years covered by Open Payments, Dr. Smith received a total of $306,777 from 52 pharmaceutical and/or device companies across 1226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Smith is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in GA
$306,777 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,080
Medicare services
Top 9% in GA for procedural dermatology physician
5,735
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~583 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
5,119 | $4 | $38 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,549 | $57 | $105 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,506 | $39 | $114 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
538 | $35 | $76 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
510 | $65 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
293 | $81 | $176 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
236 | $70 | $148 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
184 | $75 | $149 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
153 | $115 | $450 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
148 | $347 | $1,279 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
147 | $97 | $672 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
95 | $35 | $90 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
86 | $89 | $427 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $105 | $205 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
66 | $214 | $428 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
63 | $52 | $125 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
49 | $93 | $583 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
48 | $312 | $595 |
| Complex repair of eyelid, nose, ear, or lip wound, 2.6-7.5 cm A surgical procedure to repair a complex wound on the eyelid, nose, ear, or lip that measures between 2.6 and 7.5 centimeters. |
42 | $368 | $1,515 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
40 | $44 | $132 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
30 | $96 | $514 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
24 | $223 | $467 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
19 | $60 | $203 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
18 | $77 | $187 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
16 | $31 | $89 |
| Surgical removal of skin cancer, 2.1-3.0 cm Surgical excision of a cancerous skin growth measuring 2.1 to 3.0 centimeters from the scalp, neck, hands, feet, or genitals. |
15 | $110 | $636 |
| Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters. |
11 | $111 | $767 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$306,777
Total received (2018-2024)
Avg $43,825/year across 7 years
Top 8% in GA for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,226
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$240,413 (78.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50,342 (16.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,022 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$51,353
2023
$56,405
2022
$44,726
2021
$18,483
2020
$9,792
2019
$71,828
2018
$54,190
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$11,394
Galderma Laboratories, L.P.
$10,015
ABBVIE INC.
$9,370
UCB, Inc.
$8,506
E.R. Squibb & Sons, L.L.C.
$5,872
Verrica Pharmaceuticals Inc.
$2,657
Incyte Corporation
$1,848
Dermavant Sciences, Inc.
$285
Novartis Pharmaceuticals Corporation
$259
GENZYME CORPORATION
$218
Janssen Biotech, Inc.
$173
LEO Pharma Inc.
$172
Regeneron Healthcare Solutions, Inc.
$135
PFIZER INC.
$112
Amgen Inc.
$111
Arcutis Biotherapeutics, Inc.
$68
SUN PHARMACEUTICAL INDUSTRIES INC.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
MERZ NORTH AMERICA, INC.
$19
Ortho Dermatologics, a division of Bausch Health US, LLC
$18
Teva Pharmaceuticals USA, Inc.
$14
Genentech USA, Inc.
$14
Top 3 companies account for 59.9% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$78,264
Novartis Pharmaceuticals Corporation
$32,122
Lilly USA, LLC
$31,816
UCB, Inc.
$26,067
Incyte Corporation
$21,041
Sun Pharmaceutical Industries Inc.
$17,481
Galderma Laboratories, L.P.
$10,837
ABBVIE INC.
$9,745
Genentech USA, Inc.
$8,610
LEO Pharma Inc.
$8,595
Almirall LLC
$6,772
E.R. Squibb & Sons, L.L.C.
$6,619
Pfizer Inc.
$6,579
AbbVie Inc.
$5,462
Ortho Dermatologics, a division of Bausch Health US, LLC
$4,885
EPI Health, LLC
$4,801
Arcutis Biotherapeutics, Inc.
$3,296
Janssen Biotech, Inc.
$2,923
GENZYME CORPORATION
$2,678
Verrica Pharmaceuticals Inc.
$2,672
DERMIRA, INC.
$2,021
SUN PHARMACEUTICAL INDUSTRIES INC.
$1,814
DUSA Pharmaceuticals, Inc.
$1,719
Journey Medical Corporation
$1,426
Medimetriks Pharmaceuticals, Inc.
$1,380
Merz North America, Inc.
$1,252
STRATA Skin Sciences, Inc.
$920
Regeneron Healthcare Solutions, Inc.
$900
Encore Dermatology Inc.
$835
AbbVie, Inc.
$540
Amgen Inc.
$524
Dermavant Sciences, Inc.
$479
MERZ NORTH AMERICA, INC.
$246
Biofrontera Inc.
$234
Celgene Corporation
$219
VYNE Pharmaceuticals Inc.
$203
MAYNE PHARMA INC.
$139
Mayne Pharma Inc.
$138
Janssen Scientific Affairs, LLC
$138
Sandoz Inc.
$83
SANOFI-AVENTIS U.S. LLC
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Aclaris Therapeutics, Inc.
$30
Merck Sharp & Dohme Corporation
$23
Sensus Healthcare, Inc.
$22
Mission Pharmacal Company
$17
Mylan Pharmaceuticals Inc.
$15
Teva Pharmaceuticals USA, Inc.
$14
Nabriva Therapeutics, plc
$14
Novum Pharma, LLC
$14
Paratek Pharmaceuticals, Inc.
$13
Glenmark Therapeutics Inc.
$5
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · APEXICON E · ARAZLO · Absorica LD · Aczone · Alcortin A · Ameluz · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Ceracade · Cimzia · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EUCRISA · Ecoza · Enbrel · Erivedge · Exelderm · HUMIRA · HYRIMOZ · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · KERYDIN · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Mupirocin Cream · NUZYRA · Neo-Synalar · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olumiant · Olux · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · SEYSARA · SILIQ · SIMLANDI · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Sivextro · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Targadox · Tremfya · ULTRAVATE · VTAMA · WYNZORA · Winlevi · XEOMIN · XIMINO (minocycline hydrochloride) extended-release capsules · XOLAIR · XTRAC · Xeomin · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in procedural dermatology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for procedural dermatology physician in GA.
Geographic Context
Procedural dermatology physicians within 10 mi
1
Per 100K population
1.0
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Smith is a clinical cardiology specialist, with above-average Medicare volume (top 9% in GA), with speaking/promotional industry engagement in the top 8% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Smith experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Smith performed 5,119 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $306,777 from 52 companies across 1,226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smith's costs compare to other procedural dermatology physicians in Rome?
Dr. Smith's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Procedural Dermatology Physicians in Rome
Browse procedural dermatology physicians in Rome ranked by procedure volume and transparency data.
Highest volume
Top Procedural Dermatology Physicians in GA
Procedural dermatology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Procedural Dermatology Physicians in GA
Which GA procedural dermatology physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology